{"id":"https://openalex.org/W4393072964","doi":"https://doi.org/10.1158/1538-7445.am2024-2372","title":"Abstract 2372: ATG-102, a novel LILRB4 x CD3 T cell engager, targeting two nonoverlapping epitopes of LILRB4, for the treatment of monocytic AML","display_name":"Abstract 2372: ATG-102, a novel LILRB4 x CD3 T cell engager, targeting two nonoverlapping epitopes of LILRB4, for the treatment of monocytic AML","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393072964","doi":"https://doi.org/10.1158/1538-7445.am2024-2372"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-2372","doi":"https://doi.org/10.1158/1538-7445.am2024-2372","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-2372","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090336939","display_name":"Ao Sun","orcid":"https://orcid.org/0000-0002-3217-0149","observed_orcids":["https://orcid.org/0000-0002-3217-0149"]},"institutions":[{"id":"https://openalex.org/I4405267614","display_name":"Antengene Corporation Limited (China)","ror":"https://ror.org/03k1txv26","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ao Sun","raw_affiliation_strings":["1Antengene Corporation Co., Ltd., Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antengene Corporation Co., Ltd., Shanghai, China;","institution_ids":["https://openalex.org/I4405267614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020296526","display_name":"Mengshi Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mengshi Gao","raw_affiliation_strings":["2Antengene Biologics, Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Antengene Biologics, Hangzhou, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rong Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267614","display_name":"Antengene Corporation Limited (China)","ror":"https://ror.org/03k1txv26","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rong Guo","raw_affiliation_strings":["1Antengene Corporation Co., Ltd., Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antengene Corporation Co., Ltd., Shanghai, China;","institution_ids":["https://openalex.org/I4405267614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120314005","display_name":"Huiling Liu","orcid":"https://orcid.org/0000-0003-1423-8282","observed_orcids":["https://orcid.org/0000-0003-1423-8282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huiling Liu","raw_affiliation_strings":["2Antengene Biologics, Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Antengene Biologics, Hangzhou, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113149841","display_name":"Zaoshun Hu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zaoshun Hu","raw_affiliation_strings":["2Antengene Biologics, Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Antengene Biologics, Hangzhou, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006622897","display_name":"Enlin Zheng","orcid":"https://orcid.org/0009-0001-0067-2910","observed_orcids":["https://orcid.org/0009-0001-0067-2910"]},"institutions":[{"id":"https://openalex.org/I4405267614","display_name":"Antengene Corporation Limited (China)","ror":"https://ror.org/03k1txv26","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Enlin Zheng","raw_affiliation_strings":["1Antengene Corporation Co., Ltd., Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antengene Corporation Co., Ltd., Shanghai, China;","institution_ids":["https://openalex.org/I4405267614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030401301","display_name":"Hui Yuwen","orcid":"https://orcid.org/0009-0002-1326-7954","observed_orcids":["https://orcid.org/0009-0002-1326-7954"]},"institutions":[{"id":"https://openalex.org/I4405267614","display_name":"Antengene Corporation Limited (China)","ror":"https://ror.org/03k1txv26","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui Yuwen","raw_affiliation_strings":["1Antengene Corporation Co., Ltd., Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antengene Corporation Co., Ltd., Shanghai, China;","institution_ids":["https://openalex.org/I4405267614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100338483","display_name":"Peng Chen","orcid":"https://orcid.org/0000-0003-3463-0708","observed_orcids":["https://orcid.org/0000-0003-3463-0708"]},"institutions":[{"id":"https://openalex.org/I4405267614","display_name":"Antengene Corporation Limited (China)","ror":"https://ror.org/03k1txv26","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng Chen","raw_affiliation_strings":["1Antengene Corporation Co., Ltd., Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antengene Corporation Co., Ltd., Shanghai, China;","institution_ids":["https://openalex.org/I4405267614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001996286","display_name":"Jay M. Mei","orcid":"https://orcid.org/0009-0000-6211-4175","observed_orcids":["https://orcid.org/0009-0000-6211-4175"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jay Mei","raw_affiliation_strings":["3Antengene Corporation Co., Ltd., Shaoxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Antengene Corporation Co., Ltd., Shaoxing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104263009","display_name":"Bo Shan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bo Shan","raw_affiliation_strings":["3Antengene Corporation Co., Ltd., Shaoxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Antengene Corporation Co., Ltd., Shaoxing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048307356","display_name":"Bing Hou","orcid":"https://orcid.org/0000-0002-8348-3831","observed_orcids":["https://orcid.org/0000-0002-8348-3831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Hou","raw_affiliation_strings":["3Antengene Corporation Co., Ltd., Shaoxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Antengene Corporation Co., Ltd., Shaoxing, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"2372","last_page":"2372"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.4844000041484833,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.4844000041484833,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.2290000021457672,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.05609999969601631,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9190000295639038},{"id":"https://openalex.org/keywords/leukemia-stem-cells","display_name":"leukemia stem cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.7879999876022339},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.47699999809265137},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.38600000739097595},{"id":"https://openalex.org/keywords/leukemia-immunotherapy","display_name":"leukemia immunotherapy","score":0.40799999237060547},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6566468477249146},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.478426992893219},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4635421931743622},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.44844183325767517},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4363687038421631},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.33231231570243835},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3138716220855713},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26189833879470825},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26122695207595825},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.1858064830303192},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.16004794836044312},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.06592220067977905}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-2372","doi":"https://doi.org/10.1158/1538-7445.am2024-2372","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-2372","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409624587","https://openalex.org/W4388084447","https://openalex.org/W4409632446","https://openalex.org/W2886509896","https://openalex.org/W7168080431","https://openalex.org/W7148907288","https://openalex.org/W4365511888","https://openalex.org/W4367603807","https://openalex.org/W4362543373","https://openalex.org/W4393071350"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Acute":[2],"myeloid":[3],"leukemia":[4,11,46],"(AML)":[5],"is":[6,95,366],"the":[7,15,37,75,92,181,187,205,209,304,369,390,485,494],"most":[8],"common":[9],"acute":[10],"in":[12,155,160,163,227,250,258,373,384,401,433,436],"adults,":[13],"and":[14,47,61,97,105,162,236,246,262,286,319,327,339,396,419,425,435],"treatment":[16,38,486],"of":[17,39,52,77,142,184,186,190,200,208,222,230,254,289,306,322,363,368,415,443,482,487,493],"AML,":[18],"especially":[19],"monocytic":[20,101,427,488],"AML":[21,60,103,428,489],"subtypes":[22,104],"still":[23],"has":[24],"a":[25,123,156,171,191,217,228,259,277,351,470],"poor":[26],"outcome.":[27],"T":[28,129,146,238,241,315,323,421,475],"cell":[29,45,130,239,242,324,476],"engagers":[30],"(TCE)":[31],"have":[32],"been":[33],"well":[34],"used":[35],"for":[36,80,118,233,484,497],"hematological":[40],"malignancies,":[41],"such":[42],"as":[43],"B":[44],"multiple":[48],"myeloma.":[49],"However,":[50,302],"lack":[51],"ideal":[53,116],"target":[54,117],"antigens":[55],"that":[56],"only":[57],"express":[58],"on":[59,68,100,109,133],"leukemic":[62],"stem":[63,71],"cells":[64,72,264,275,298,349,422],"(LSCs)":[65],"but":[66,107],"not":[67,108],"normal":[69,110],"hematopoietic":[70],"(HSCs)":[73],"hampers":[74],"development":[76],"TCE":[78],"therapy":[79],"AML.":[81],"Leukocyte":[82],"immunoglobulin-like":[83],"receptor":[84,89],"B4":[85],"(LILRB4),":[86],"an":[87,115],"inhibitory":[88],"belonging":[90],"to":[91,180,204,272,283,296,423],"LILR":[93],"family,":[94],"highly":[96],"restrictedly":[98],"expressed":[99],"M4/M5":[102],"LSCs,":[106],"HSCs":[111],"which":[112,365],"makes":[113],"it":[114,340],"TCE.":[119],"Here":[120],"we":[121],"report":[122],"novel":[124,471],"LILRB4":[125,192,201,273,300,307,472],"x":[126,473],"CD3":[127,474],"bispecific":[128],"engager":[131],"based":[132],"AnTenGagerTM":[134],"platform,":[135],"ATG-102.":[136],"It":[137,281,430],"targets":[138],"two":[139,284,479],"distinct":[140,285],"epitopes":[141,288,481],"LILRB4,":[143,416,483],"inducing":[144],"potent":[145,157,343,383,432],"cell-dependent":[147],"cellular":[148],"cytotoxicity":[149,244],"(TDCC)":[150],"with":[151,276,303,356,389,440],"low":[152,441],"CRS,":[153],"resulting":[154],"anti-tumor":[158,386,438],"efficacy":[159,253,387,439],"vitro":[161,434],"vivo.":[164],"Method:":[165],"ATG-102":[166,224,255,270,291,311,330,358,380,409],"was":[167,202,225,256],"constructed":[168],"by":[169,213],"introducing":[170],"high":[172],"affinity":[173],"anti-CD3":[174],"single":[175],"chain":[176,212],"fragment":[177],"variable":[178],"(scFv)":[179],"hinge":[182],"region":[183],"one":[185,367],"heavy":[188,211],"chains":[189],"monoclonal":[193],"antibody.":[194,353],"A":[195],"scFv":[196],"targeting":[197,478],"another":[198],"epitope":[199,220,235,413],"connected":[203],"C":[206],"terminal":[207],"same":[210],"GSSS":[214],"linker,":[215],"enabling":[216],"trivalent,":[218,411],"dual":[219,412],"recognition":[221,414],"LILRB4.":[223,290],"evaluated":[226,257],"series":[229],"preclinical":[231],"studies":[232],"binding":[234,294],"affinity,":[237],"activation,":[240,325],"dependent":[243],"(TDCC),":[245],"cytokine":[247,374],"release.":[248],"The":[249],"vivo":[251,385,437],"antitumor":[252],"humanized":[260],"PBMCs":[261],"THP-1-luciferase":[263,406],"engrafted":[265],"NCG":[266,403],"mice":[267,404],"model.":[268],"Results:":[269],"binds":[271,282],"positive":[274,308],"single-digit":[278],"nM":[279],"affinity.":[280],"nonoverlapping":[287,480],"showed":[292],"limited":[293],"capability":[295],"CD3+":[297],"before":[299],"crosslinking.":[301],"presence":[305],"THP-1":[309,337],"cell,":[310],"strongly":[312],"activated":[313],"primary":[314],"cells,":[316,338],"upregulating":[317],"early":[318],"later":[320],"markers":[321],"CD69":[326],"CD25,":[328],"respectively.":[329],"induced":[331,341,359],"strong":[332],"TDCC":[333,344],"against":[334,345],"LILRB4-high":[335],"expressing":[336,347],"more":[342,382],"LILRB4-low":[346],"MOLM-13":[348],"than":[350],"benchmark":[352,391],"While":[354],"compared":[355,388],"benchmark,":[357],"significantly":[360],"lower":[361],"release":[362,375],"IL-6,":[364],"major":[370],"cytokines":[371],"involved":[372],"syndrome":[376],"(CRS).":[377],"In":[378],"addition,":[379],"demonstrated":[381],"antibody":[392],"at":[393],"1":[394,504],"mg/kg":[395,398],"0.1":[397],"dose":[399],"level":[400],"PBMC-humanized":[402],"bearing":[405],"cells.":[407,429],"Conclusion:":[408],"demonstrates":[410,431],"conditionally":[417],"redirects":[418],"activates":[420],"recognize":[424],"kill":[426],"risk":[442],"CRS.":[444],"Citation":[445],"Format:":[446],"Ao":[447],"Sun,":[448],"Mengshi":[449],"Gao,":[450],"Rong":[451],"Guo,":[452],"Huiling":[453],"Liu,":[454],"Zaoshun":[455],"Hu,":[456],"Enlin":[457],"Zheng,":[458],"Hui":[459],"Yuwen,":[460],"Peng":[461],"Chen,":[462],"Jay":[463],"Mei,":[464],"Bo":[465],"Shan,":[466],"Bing":[467],"Hou.":[468],"ATG-102,":[469],"engager,":[477],"[abstract].":[490],"In:":[491],"Proceedings":[492],"American":[495],"Association":[496],"Cancer":[498,516],"Research":[499],"Annual":[500],"Meeting":[501],"2024;":[502],"Part":[503],"(Regular":[505],"Abstracts);":[506],"2024":[507],"Apr":[508],"5-10;":[509],"San":[510],"Diego,":[511],"CA.":[512],"Philadelphia":[513],"(PA):":[514],"AACR;":[515],"Res":[517],"2024;84(6_Suppl):Abstract":[518],"nr":[519],"2372.":[520]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-03-23T00:00:00"}